farmacologia 2

Prévia do material em texto

9·Ĺĕ·Ðĝďĝðû·
9·Ĺĕ·ÐĝÖûĖÀĕûз
��([LVWHP YiULDV IRUPDV H YLDV GH DGPLQLVWUDomR
GH XP IiUPDFR� 3RU TXH D DGPLQLVWUDomR GH XP
IiUPDFR SRU YLD LQWUDYHQRVD QmR GHSHQGH GR
SURFHVVR GH DEVRUomR SHOR RUJDQLVPR"
$� 3RU VH HQFRQWUDU HP VXD IRUPD PDLV SXUD
VHP LQWHUDomR PHGLFDPHQWRVD�
%� 3RU VHU LQMHWDGR GLUHWDPHQWH QD FRUUHQWH
VDQJXtQHD�
&� 'HYLGR D VXD DOWD FRQFHQWUDomR�
'� 3RU HVWDU HP IRUPD GH VROXomR GR IiUPDFR�
�� 2V UHFHSWRUHV DGUHQpUJLFRV SRGHP VHU
DWLYDGRV SRU DGUHQDOLQD� QRUDGUHQDOLQD H GURJDV
VLPSDWLFRPLPpWLFDV�
$� 9HUGDGHLUR
%� )DOVR
�� 6REUH DV 5HDo}HV DGYHUVDV D PHGLFDPHQWRV
DQDOLVH DV DVVHUWLYDV D VHJXLU H DVVLQDOH D
DOWHUQDWLYD FRUUHWD�
, � e TXDOTXHU UHVSRVWD SUHMXGLFLDO RX
LQGHVHMiYHO� QmR LQWHQFLRQDO� D XP
PHGLFDPHQWR� TXH RFRUUH QDV GRVHV
XVXDOPHQWH HPSUHJDGDV QR KRPHP SDUD
SURILOD[LD� GLDJQyVWLFR� WHUDSLD GD GRHQoD RX
SDUD D PRGLILFDomR GH IXQo}HV ILVLROyJLFDV�
,, � e GHILQLGD FRPR LQH[LVWrQFLD RX UHGXomR GD
UHVSRVWD WHUDSrXWLFD HVSHUDGD GH XP
PHGLFDPHQWR DGPLQLVWUDGR GH DFRUGR FRP DV
FRQGLo}HV GH XVR SUHVFULWDV RX LQGLFDGDV HP
EXOD�
,,, � (VWDV UHDo}HV VmR XP SUREOHPD LPSRUWDQWH
QD SUiWLFD FOtQLFD� SRLV VmR FDXVDV GH
KRVSLWDOL]DomR� DXPHQWR GR WHPSR GH
LQWHUQDPHQWR H DWp PHVPR yELWR�
$�$SHQDV D , HVWi FRUUHWD�
%� $SHQDV D ,,, HVWi FRUUHWD�
&� $SHQDV , H ,, HVWmR FRUUHWDV�
'� $SHQDV , H ,,, HVWmR FRUUHWDV�
��2V EHQ]RGLD]HStQLFRV VmR XPD FODVVH GH
PHGLFDPHQWRV GH WDUMD SUHWD TXH WrP FRPR
FDUDFWHUtVWLFD HP FRPXP GLPLQXLU D DWLYLGDGH GR
VLVWHPD QHUYRVR FHQWUDO� $ DVVLVWHQWH
WR[LFROyJLFD H IDUPDFrXWLFD ELRTXtPLFD GR
&HDWR[ :HOOLQJWD &UL]RVWRPR *RPHV &RUUHLD
H[SOLFD TXH D GURJD PDLV IUHTXHQWH p R
PLGD]RODP� XP VHGDWLYR PXLWR XVDGR HP
H[DPHV GH HQGRVFRSLD RX FRPR SUp�DQHVWpVLFR�
�3HODV FDUDFWHUtVWLFDV GHOH QR RUJDQLVPR�
TXDQGR DVVRFLDGR SULQFLSDOPHQWH FRP iOFRRO >R
PLGD]RODP@ Mi FDXVD HVVH HIHLWR TXH D JHQWH
FKDPD GH GLVVRFLDWLYR� $ YtWLPD WHP XP
FRPSURPHWLPHQWR GH UHDOLGDGH� GH PHPyULD���
(OH p DEVRUYLGR UDSLGDPHQWH H p HOLPLQDGR GR
FRUSR PXLWR UiSLGR� FHUFD GH �� KRUDV GHSRLV�
0XLWDV YH]HV YRFr QmR YDL WHU D SURYD QR
RUJDQLVPR GD SHVVRD FDVR WHQKD XP H[DPH
WR[LFROyJLFR� SRU H[HPSOR�� >���@
'H DFRUGR FRP R IUDJPHQWR GD QRWtFLD
DSUHVHQWDGD� R PLGD]RODP p HOLPLQDGR PXLWR
UiSLGR GR FRUSR� $ SULQFLSDO YLD GH H[FUHomR GH
IiUPDFRV p D�
$� 9LD UHWDO
%� 9LD ELOLDU
&� 9LD UHQDO
'� 9LD SXOPRQDU
��(P UHODomR DRV SULQFtSLRV IDUPDFRGLQkPLFRV�
DVVLQDODU D DOWHUQDWLYD ,1&255(7$�
$� $V GURJDV DJRQLVWDV OLJDP�VH DR UHFHSWRU H
LPSHGHP D DomR GR DQWDJRQLVWD VHP FDXVDU
HIHLWRV
%� 2 IiUPDFR LQWHUDJH FRP R UHFHSWRU H LQLFLD
XPD FDGHLD GH HYHQWRV TXH OHYD DRV HIHLWRV
GHVVH IiUPDFR�
&� 3RWrQFLD p D TXDQWLGDGH GH IiUPDFR
QHFHVViULD SDUD FDXVDU HIHLWR� 4XDQWR PDLRU D
SRWrQFLD� PHQRU D TXDQWLGDGH GH IiUPDFR SDUD
DWLQJLU R HIHLWR�
'� $V GURJDV DJRQLVWDV VLPXODP R HIHLWR GH
FRPSRVWRV HQGyJHQRV H GHVHQFDGHLDP D
PHVPD DomR�
��4XDO D GLIHUHQoD HQWUH DJRQLVWD H
DQWDJRQLVWD"
��([SOLTXH RV WHUPRV DEDL[R�
-
↳
recepticsligadosdas Simprenalinae
↓
Efeitorar bens,ee
*
↳
antagonista
* -
-
lasimula o
- efeito da subst.
impede a acaodo endógena
⑰ agonista, semcausar
efeito
$� %LRGLVSRQLELOLGDGH
%� (IHLWR GH SULPHLUD SDVVDJHP
&� 6LPSDWLFRPLPpWLFR
'� 0HLD�9LGD SODVPiWLFD
(� &L3���
Porcentagem do fármaco que
vai
atingir a circulacaosanguinea
depois
do metabolismo no figade
Aconcentraçardo farmace ereduzida
pelo figado antes
de atingir a circulaç
imita o efeito do
neurotransmissor NEIEdo
S.N. Simpático
Tempo gasto para que
o fármaco no organism
Se reduza a metade apósa sua administrador
Enzimas que atuam
na metabolizaras,
aumentando a solubilidade
do fármaco,
facilitando sua excreção